
Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
... Including roche, a cancer drug with sales recently forecasted to $7 billion out to 2015; and tecfidera, the new multiple sclerosis drug that made it to market in less than a 3 week of being approved ...
... In revenues last year, and earned $177.5 Million in net income. Its cro division generated 74% of its revenues. Also noted: quintiles helped develop or commercialize 85% of the central nervous system drugs ...
... Agreement, the company and its subsidiaries will cease to engage in the distribution, sales and promotion of vaccines and cold-chain pharmaceutical products, directly or indirectly, as these businesses ...
Summary DNAVEC Corporation (DNAVEC) is a biotechnology company, based in Japan. It develops technologies such as, sendai virus vector and simian immunodeficiency virus vector. The company's products include ...
Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is a pharmaceutical and healthcare company, based in China. The company discovers, develops, and commercializes drug candidates. ...
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
Reportlinker.com © Copyright 2013. All rights reserved.